AI assistant
Sending…
AbbVie Inc. — Director's Dealing 2017
Mar 30, 2017
29755_dirs_2017-03-30_73dc05ea-2613-4413-867c-88172bf83f77.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REATA PHARMACEUTICALS INC (RETA)
CIK: 0001358762
Period of Report: 2017-03-28
Reporting Person: AbbVie Inc. (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-03-28 | Class A Common Stock | S | 450000 | $22.50 | Disposed | 1190473 | Direct |
More from AbbVie Inc.
Regulatory Filings
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 29
Capital/Financing Update
2026
Apr 3
Major Shareholding Notification
2026
Mar 26
Proxy Solicitation & Information Statement
2026
Mar 23
Proxy Solicitation & Information Statement
2026
Mar 23
Capital/Financing Update
2026
Mar 4
Director's Dealing
2026
Mar 4